Medication use and treatment patterns in children and adolescents with chronic tic disorders: an EMTICS study

Study limitation reported by the research below: “Data were collected 2013–2015; guanfacine received European approval in 2015, so alpha-2 agonist underuse figures are partly a regulatory artifact rather than purely a prescriber preference.”